Thursday, Jun 30, 2016
One of America's Great Newspapers ~ Toledo, Ohio

Medical

Ohio gets $52.7M share of drug settlement

Part of $2.2B from J&J payment to resolve unapproved drug marketing allegations

COLUMBUS — Ohio’s Medicaid program will receive $52.7 million through a national settlement with a pharmaceutical company.

The $2.2 billion settlement announced Monday involves Johnson & Johnson, one of its subsidiaries, the federal government and several states.

The allegations include paying kickbacks to physicians and pharmacies to recommend and prescribe Risperdal and Invega, both antipsychotic drugs, and Natrecor, which is used to treat heart failure.

The figure includes $1.72 billion in civil settlements with federal and state governments as well as $485 million in criminal fines and forfeited profits.

The agreement is the third-largest U.S. settlement involving a drug maker, and the latest in a string of legal actions against drug companies that allegedly put profits ahead of patients.

Click to comment

Quis autem vel eum iure reprehenderit qui in ea voluptate velit esse quam nihil molestiae consequatur, vel illum qui dolorem?

Temporibus autem quibusdam et aut officiis debitis aut rerum necessitatibus saepe eveniet.

Copyright © 2015 Toledo Blade

To Top

Fetching stories…